0,023€
4,59%
Echtzeit-Aktienkurs Mountain Valley MD Holdings Inc.
Bid:
Ask:
Echtzeit-Chart der Mountain Valley MD Holdings Inc. Aktie
Börsenkurse Mountain Valley MD Holdings Inc.
| Börse Frankfurt | - | - | - | - | 0,023€ | 93,22% |
| Tradegate | - | - | - | - | 0,023€ | 4,59% |
| Börse Stuttgart | - | - | - | - | 0,025€ | 19,05% |
| gettex | - | - | - | - | 0,023€ | 9,52% |
| Echtzeit Euro | - | - | - | - | 0,025€ | 113,56% |
Fundamentaldaten der Mountain Valley MD Holdings Inc. Aktie
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2024 [CAD] | 0,06 Mio. | -7,76 Mio. | -7,67 Mio. | -0,02 | - | - | 125,27 |
| 2023 [CAD] | - | -7,33 Mio. | -7,44 Mio. | -0,02 | - | - | - |
| 2022 [CAD] | 0,11 Mio. | -10,05 Mio. | -9,71 Mio. | -0,03 | - | - | 68,31 |
| 2021 [CAD] | - | -8,02 Mio. | -8,14 Mio. | -0,03 | - | - | - |
| 2020 [CAD] | - | -18,76 Mio. | -18,84 Mio. | -0,09 | - | - | - |
| 2019 [CAD] | - | -22,85 Mio. | -22,85 Mio. | -3,65 | - | - | - |
| 2018 [CAD] | - | -0,96 Mio. | -0,96 Mio. | -0,24 | - | - | - |
| 2017 [CAD] | - | -0,80 Mio. | -0,80 Mio. | -0,32 | - | - | - |
| 2016 [CAD] | - | -1,43 Mio. | -1,43 Mio. | -0,64 | - | - | - |
| 2015 [CAD] | - | -1,57 Mio. | -1,57 Mio. | -0,96 | - | - | - |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. |
Profil der Mountain Valley MD Holdings Inc. Aktie
Mountain Valley MD Holdings, Inc. is a biotech company, which engages in the implementation of its patented Quicksome oral delivery technologies across molecules in nutraceutical, vaccine, and pharmaceutical drug applications. Its Patented Technologies includes Quicksome™ and Quicksol™. The Quicksome™ patented technology utilizes proprietary formulations and stabilizing molecules to encapsulate and formulate active ingredients into highly efficient product formats that, if successfully commercialized, could enhance the efficacy of molecule delivery across a variety of nutraceutical product applications. The Quicksol™ patented is a solubilization technology, which has been developed to provide solubilized drug delivery options. The company was founded on March 8, 2005 and is headquartered in Vaughan, Canada.